The inhibition of VEGF-A does not revert these processes, suggesting that another pro-angiogenic factors secreted by surrounding ovarian cancer cells or their microenvironment could be involved in the angiogenic activation of peritoneal ECs during metastasis (18, 19). Here, VEGFA is linked to ovarian carcinoma.